Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Nutex Health (NUTX) Income from Non-Controlling Interests (2020 - 2025)

Historic Income from Non-Controlling Interests for Nutex Health (NUTX) over the last 6 years, with Q3 2025 value amounting to $41.4 million.

  • Nutex Health's Income from Non-Controlling Interests rose 244861.37% to $41.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $143.1 million, marking a year-over-year increase of 153964.16%. This contributed to the annual value of $42.7 million for FY2024, which is 170750.19% up from last year.
  • Per Nutex Health's latest filing, its Income from Non-Controlling Interests stood at $41.4 million for Q3 2025, which was up 244861.37% from $33.8 million recorded in Q2 2025.
  • Nutex Health's Income from Non-Controlling Interests' 5-year high stood at $41.4 million during Q3 2025, with a 5-year trough of -$10.7 million in Q3 2022.
  • Moreover, its 5-year median value for Income from Non-Controlling Interests was $2.6 million (2021), whereas its average is $8.7 million.
  • Its Income from Non-Controlling Interests has fluctuated over the past 5 years, first crashed by 27999.03% in 2022, then surged by 1672303.37% in 2025.
  • Nutex Health's Income from Non-Controlling Interests (Quarter) stood at -$504528.0 in 2021, then soared by 911.37% to $4.1 million in 2022, then decreased by 4.57% to $3.9 million in 2023, then skyrocketed by 879.73% to $38.3 million in 2024, then grew by 8.07% to $41.4 million in 2025.
  • Its last three reported values are $41.4 million in Q3 2025, $33.8 million for Q2 2025, and $29.6 million during Q1 2025.